Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 3
2020 3
2021 11
2022 34
2023 31
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 35138784

74 results

Results by year

Filters applied: . Clear all
Page 1
Molnupiravir.
[No authors listed] [No authors listed] 2022 Jan 31. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2022 Jan 31. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 35138784 Free Books & Documents. Review.
Molnupiravir and Its Antiviral Activity Against COVID-19.
Tian L, Pang Z, Li M, Lou F, An X, Zhu S, Song L, Tong Y, Fan H, Fan J. Tian L, et al. Front Immunol. 2022 Apr 4;13:855496. doi: 10.3389/fimmu.2022.855496. eCollection 2022. Front Immunol. 2022. PMID: 35444647 Free PMC article. Review.
Paxlovid.
[No authors listed] [No authors listed] 2022 Jan 31. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2022 Jan 31. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 35138785 Free Books & Documents. Review.
Molnupiravir-A Novel Oral Anti-SARS-CoV-2 Agent.
Lee CC, Hsieh CC, Ko WC. Lee CC, et al. Antibiotics (Basel). 2021 Oct 23;10(11):1294. doi: 10.3390/antibiotics10111294. Antibiotics (Basel). 2021. PMID: 34827232 Free PMC article.
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus.
Fischer WA 2nd, Eron JJ Jr, Holman W, Cohen MS, Fang L, Szewczyk LJ, Sheahan TP, Baric R, Mollan KR, Wolfe CR, Duke ER, Azizad MM, Borroto-Esoda K, Wohl DA, Coombs RW, James Loftis A, Alabanza P, Lipansky F, Painter WP. Fischer WA 2nd, et al. Sci Transl Med. 2022 Jan 19;14(628):eabl7430. doi: 10.1126/scitranslmed.abl7430. Epub 2022 Jan 19. Sci Transl Med. 2022. PMID: 34941423 Free PMC article. Clinical Trial.
Efficacy and Safety of Molnupiravir in Mild COVID-19 Patients in India.
Sinha S, N K, Suram VK, Chary SS, Naik S, Singh VB, Jain MK, Suthar CP, Borthakur S, Sawardekar V, Sk N, Reddy N, Talluri L, Thakur P, Reddy M, Panapakam M, Vattipalli R. Sinha S, et al. Cureus. 2022 Nov 14;14(11):e31508. doi: 10.7759/cureus.31508. eCollection 2022 Nov. Cureus. 2022. PMID: 36532902 Free PMC article.
Remdesivir.
[No authors listed] [No authors listed] 2022 Feb 3. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2022 Feb 3. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 33211457 Free Books & Documents. Review.
74 results